Mapi Pharma raised €8.4M in a funding round in Sep 2017. The company is based in Ness Ziona, Israel. Investors in the round: Shavit Capital. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
